Stay updated with breaking news from Tim Oldham. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
AdAlta Limited , the clinical stage drug discovery company developing novel therapeutic products from its i-body platform, today announced that its CEO and Managing Director, Dr Tim Oldham, would be... | May 30, 2023
AdAlta Ltd (ASX:1AD) managing director Dr Tim Oldham tells Proactive the company’s rights offer has raised A$1.28 million before costs, with commitments in...
From cell therapies and cancer research to COVID-19 and CBD capsules, healthcare stocks are hard at work developing the next generation of diagnostic and...
AdAlta Ltd (ASX:1AD) managing director Dr Tim Oldham tells Proactive the company is seeking an early return to clinical trials of its lead asset, AD-214,...
AdAlta Ltd (ASX:1AD) is seeking an early return to clinical trials of its lead asset, AD-214, with a $3.5 million non-renounceable rights offer. The...